Intercept pharmaceuticals, inc. (ICPT)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12
Cash flows from operating activities:
Net loss

-92,983

-98,158

-84,833

-71,420

-90,270

-88,005

-64,454

-75,193

-81,590

-111,272

-72,601

-86,564

-89,930

-120,041

-88,816

-77,299

-126,674

-88,254

-50,895

-47,894

-39,386

-34,824

-35,843

33,469

-246,028

-12,367

-31,737

-13,476

-10,210

-30,690

-5,186

-5,085

-2,679

Adjustments to reconcile net loss to net cash used in operating activities:
Foreign currency loss on liquidation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-383

0

191

0

Revaluation of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-55,794

226,626

-1,569

20,756

5,572

3,682

24,187

1,417

-301

-677

Stock-based compensation

12,473

13,173

13,130

14,782

14,897

11,499

11,994

14,116

12,305

15,384

13,237

14,286

14,061

19,164

12,544

4,253

10,244

12,151

5,669

6,631

9,738

3,663

5,234

3,794

7,435

2,967

2,980

1,890

1,607

2,097

490

369

391

(Accretion) amortization of (discount) premium on investment debt securities

-536

-293

25

271

299

299

267

-31

-502

-6,206

851

904

1,022

-8,675

1,072

1,121

1,543

1,785

1,922

1,711

884

975

1,021

818

551

538

547

528

0

118

0

0

0

Amortization of deferred financing costs

614

601

571

552

406

398

390

381

373

365

358

351

343

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from sale of assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

Depreciation

764

861

-1,771

3,614

996

1,049

1,123

1,138

1,290

1,344

1,382

1,072

802

1,644

643

860

684

632

413

396

250

233

80

68

61

26

26

29

22

-

-

79

74

Non-cash operating lease cost

1,584

-

-

-

1,404

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on lease termination

-

0

0

0

1,995

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on the disposal of fixed assets

-

0

0

1

-2,683

0

0

-430

-901

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of bonds

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

Accretion of debt discount

6,276

6,138

6,336

5,020

3,695

3,619

3,543

3,470

3,399

3,328

3,259

3,191

3,126

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Provision for allowance of credit losses

179

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets:
Accounts receivable

6,549

5,222

-3,538

6,920

3,746

3,614

2,571

2,565

443

2,014

1,257

2,605

1,499

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

7,122

2,033

-421

4,493

-752

2,826

-2,148

-916

3,920

2,611

-747

-1,323

6,994

-5,268

-8,517

2,413

7,088

6,789

-2,854

35

3,546

-898

-1,491

3,695

2,064

1,794

14

92

-187

-722

424

454

231

Inventory

2,377

-886

1,662

316

262

-367

1,662

-2,125

4,458

-417

1,215

566

-163

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Security deposits

-50

-1,544

-169

34

-883

-15

330

947

-8,415

-

-

-

-1,414

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

-

5,176

-133

-94

19,716

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating liabilities:
Accounts payable, accrued expenses and other current liabilities

-7,899

22,421

19,393

15,397

-800

22,051

3,452

5,519

-20,690

12,707

8,810

10,337

-2,628

18,261

4,597

223

-3,121

15,276

8,395

5,635

2,912

-1,255

4,576

1,374

1,504

2,180

1,407

445

-520

-344

512

2,084

-11

Operating lease liabilities

-1,690

-1,748

-1,660

-1,721

-1,638

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest payable

-2,587

2,574

-2,587

4,312

-3,737

-

-

-

-3,738

3,738

-3,738

3,737

-3,529

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

Deferred revenue

-

-1,216

-406

-1,500

690

-406

-406

-405

-805

-446

-5,499

371

-119

1,312

-973

2,235

-445

-446

-445

-446

-445

-445

-445

554

-405

-405

-405

-405

-405

-405

-523

-758

-758

Litigation settlement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

55,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term other liabilities

-

3,201

-1,477

-1,639

12,632

-507

-435

-458

-407

-490

-472

272

6,268

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in) operating activities

-98,731

-60,484

-46,756

-45,948

-83,425

-52,812

-51,581

-47,455

-88,866

-76,459

-56,138

-55,305

-77,500

-89,462

-112,102

-71,020

-69,857

-65,688

-33,619

-34,001

-29,594

-32,143

-23,866

-19,410

-12,318

-10,424

-6,437

-5,508

-5,635

-4,292

-3,688

-3,875

-3,893

Cash flows from investing activities:
Purchases of investment debt securities

34,444

42,281

108,831

446,690

5,212

57,810

83,724

266,071

28,466

104,105

46,304

59,452

21,246

68,198

408,005

0

35,318

80,781

35,874

401,840

122,214

8,367

34,625

145,628

15,723

39,593

26,449

49,538

10,243

65,940

0

0

0

Sales and maturities of investment debt securities

106,693

108,264

125,323

81,163

100,412

94,861

115,266

82,768

95,273

130,731

161,630

111,628

125,285

95,446

118,902

119,111

123,006

106,119

54,635

52,798

43,620

42,357

32,757

13,558

23,729

30,804

12,439

11,997

2,000

1,119

0

0

0

Redemptions of certificates of deposit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

117

-4

-119

4

Purchases of equipment, leasehold improvements, and furniture and fixtures

432

95

17

291

733

122

0

-44

89

290

1,864

4,213

4,025

1,074

-182

1,780

2,407

521

1,237

2,247

1,930

953

3,068

322

299

1,507

81

31

8

14

5

-1

19

Net cash provided by investing activities

71,817

65,888

16,475

-365,818

94,467

36,929

31,542

-183,259

66,718

25,395

113,433

48,933

100,014

26,174

-243,921

72,331

85,281

24,817

17,524

-351,289

-80,524

33,037

-4,936

-132,392

7,706

-10,297

-14,091

-37,572

-8,252

-64,953

-0

120

-23

Cash flows from financing activities:
Proceeds from issuance of common stock, net of issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-174

367,296

191,634

-

-

-

-

-0

-209

61,379

0

78,786

29,713

0

0

Proceeds from issuance of common stock warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

Costs associated with issuance of stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

338

-

-

-

-

-

-

-

-

Payments of capital lease obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

23

58

Proceeds from exercise of options, net

569

6,482

773

795

943

1,162

2,715

5

481

761

430

1,091

556

744

1,523

1,420

1,486

1,118

1,059

1,547

2,989

1,070

1,972

1,667

2,798

593

2,089

2,123

87

-

0

0

0

Payments of employee withholding taxes related to stock-based awards

1,322

682

-119

804

791

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

0

8

0

-

0

0

0

Proceeds from issuance of convertible promissory notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

Net cash (used in) provided by financing activities

-753

5,880

892

450,595

152

440

1,262

261,362

481

761

430

1,091

556

602

410,874

1,420

1,486

1,118

885

368,843

194,623

1,070

1,901

185,552

2,459

594

1,879

63,510

87

78,786

29,713

-23

-58

Effect of exchange rate changes on cash, cash equivalents and restricted cash

-694

119

-735

-52

282

-691

439

-1,799

525

72

488

362

205

1,145

-1,336

-235

-447

138

-690

338

-162

-

-

-

-

-

-

-

0

0

0

-19

12

Net (decrease) increase in cash, cash equivalents and restricted cash

-28,361

11,403

-30,124

38,777

11,476

-16,134

-18,338

28,849

-21,142

-50,231

58,213

-4,919

23,275

-61,541

53,515

2,496

16,463

-39,615

-15,900

-16,109

84,343

1,964

-26,902

33,750

-2,152

-20,128

-18,648

20,429

-13,800

9,540

26,024

-3,797

-3,962

Supplemental disclosures of noncash activities:
Conversion of promissory note payable, including accrued interest of $91,250 into common shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

Issuance of 108,169 warrants for private placement agent fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

Acquisition of equipment pursuant to capital leases

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

Issuance of common stock for cashless warrant exchange

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,628

1,018

0

0

0

Supplemental disclosure of cash flow information:
Cash paid during the year for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,935

0

0

-3

0

7